Teva Pharmaceutical 2024 J.P. Morgan Healthcare Conference

Teva Pharmaceutical Industries presented at the 42nd J.P. Morgan Healthcare Conference on January 8, 2024, outlining its Pivot to Growth strategy focused on expanding innovative medicines, biosimilars, and managing its substantial generic product portfolio. The presentation addresses key risks and opportunities including competition, debt management, regulatory compliance, and geopolitical impacts on operations.